Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Best and Less sales let down by delayed summer and supply chain issues, records losses of about $6 million

  • In News
  • January 25, 2023
  • Alinda Gupta
Best and Less sales let down by delayed summer and supply chain issues, records losses of about $6 million

Even as shoppers return to stores and get back on their shopping sprees, value apparel retailer Best and Less (ASX: BLG) is struggling to attract customers. In H1 FY23, the Company delivered an unaudited total revenue of $324.8 million, a 13% increase on H1 FY22. However, its EBITDA was down 28.2% to $22.1 million.

Best and Less’s like-for-like (LFL) sales were down 4.9%, with store LFL sales down 0.9% and online sales down 29.8%. 

Most stores relied on Black Friday, Christmas and Boxing Day periods to boost sales. Best and Less also benefitted from the period, recording a like-for-like sales growth of 5% in December and core non-discretionary product lines across the important baby category performed well. However, this momentum wasn’t enough to offset the impact of a delayed summer and supply chain issues that Best and Less faced. 

In the first three weeks of January, LFL sales were up 13.7%, as store sales increased 18.6% and online sales fell 23.1%. 

A lower gross profit margin percentage (47.1%) and “softer-than-expected” sales in H1 led to the Company’s net profit after tax (NPAT) declining by about $6 million, reducing from $20.1 million in H1 FY22 to $13.7 million now.

Surprisingly, even though consumers have returned to physical stores, Best and Less is not seeing enough foot traffic or demand. The Company took action—not sure what exactly—to reduce the risk of losing inventory and strengthen price perception. Excluding this, the average sale price (ASP) for H1 was 9.5% higher than the previous corresponding period. 

At the end of the first half, the total stock on hand was 8.9% higher than H1 FY22, amounting to $104 million. But, there are 5% fewer units due to changing product mix and the impact of cost increases, and the aged stock remains low at 2.2% of total inventory at the period end.

BLG Executive Chair, Jason Murray, shared, “While we are cautious on the near-term macroeconomic outlook, our vertical model and the deep retail sector experience of our team gives us the ability to respond and adapt rapidly. We will continue to invest in our ‘good, better, best’ pricing strategy, while focusing on effectively managing all controllables, including inventory and costs. Alongside this, we will continue to invest to deliver our growth strategy, with six new stores scheduled to open in the second half.”

Like Murray said, in H2 FY23, the Best and Less Group will open six new stores, including one in the Macquarie Centre in Sydney. It is also launching cost management initiatives to match current trading conditions (perhaps it will join the layoffs bandwagon).

It is still early in H2 FY23, and there is no telling what economic conditions will look like in the coming months. If all goes well, Best and Less expects to deliver a second-half pro forma NPAT of about $18 million to $20 million, still lower than the H2 FY22 NPAT of $21.4 million.

With its anticipated H1 FY23 results, the Company has set expectations for the ongoing financial year. The Company will announce its audited H1 FY23 results on February 21, 2023. 

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx blg
  • best and less
  • BLG
  • jason murray
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.